CNBC World

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.

This is a short WorldPing brief. The full report was published by CNBC World.

Read the full report at CNBC World

Related news